Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Antibe Therapeutics Inc(Pre-Merger) ATBPF

Antibe Therapeutics Inc. is a clinical-stage biotechnology company. The Company is leveraging its hydrogen sulfide (H2S) platform to develop therapies to target inflammation arising from a range of medical conditions. The Company’s pipeline includes assets that seek to overcome the gastrointestinal ulcers and bleeding associated with nonsteroidal anti-inflammatory drugs (NSAIDs). Its lead drug, otenaproxesul, is in clinical development as an alternative to opioids and NSAIDs for acute pain. Its second pipeline drug, ATB-352, is being developed for a specialized pain indication. The Company also focuses on inflammatory bowel disease (IBD). Otenaproxesul combines a moiety that releases hydrogen sulfide with naproxen, a non-steroidal, anti-inflammatory drug. ATB-352 is an H2S-releasing derivative of ketoprofen, a potent NSAID commonly prescribed for acute pain. Its IBD candidates are being designed to maintain the efficacy, safety, and pharmacokinetic properties of ATB-429.


GREY:ATBPF - Post by User

Post by Duster340on May 24, 2022 9:18am
112 Views
Post# 34703254

RE:RE: Ate

RE:RE: AteDavgro Writes: Another insightful observation from the Dumpster. 

It is obvious that you are not an "investor" in ATE from your posts.  You fancy yourself a swing trader but you don't understand the fundamentals of trading or the stocks to day/swing trade.  Now you are frustrated by the lack of daily price movements in ATE preventing you from "flipping your pennies".  You probably have no dry powder so you must watch in frustration as opportunities pass you by in a highly volatile trading market.  ATE should rebound in the future but the market will need to bottom first before biotech and pharmaceutical are back in favour.  "Fortune Favours the Brave" doesn't just apply to crypto.

Duster340 Writes: you nailed it again you are right, not only are you a stalker and a psycho but also psychic. it is true the stock price latley is frustrating, that is why i decided to dump some shares @70 cents last week, very small profit, but looks like i will be buying those shares back this morning for maybe 67 or 68 if i am lucky. nothing wrong with taking cash and then geting your shares back at a cheaper price thats a win win. of course i would have like a bigger spread on what i paid and what i sold for oh well does not always work out that way.  I know you have not learned how to make money in a bear market yet but hang in there you might figure it out.  hahaha
<< Previous
Bullboard Posts
Next >>